Blood Pressure Measurement

TO DIAGNOSE HYPERTENSIVE DISEASES OF PREGNANCY

Diagnostic
Diagnostic
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Blood Pressure Measurement

    GLOBAL ANNUAL DEATHS ASSOCIATED WITH HYPERTENSIVE DISEASES OF PREGNANCY

    PERCENT (%)
    NUMBER

    Maternal

    18%
    65,000

    Neonatal

    10-15%
    300,000 - 500,000

    Stillbirth

    10-15%
    300,000 - 500,000

    Condition
    Hypertension in pregnancy is defined as a diastolic blood pressure reading >90mm Hg or a systolic blood pressure reading >140 mmHg on two consecutive readings 4 hours apart. Devices to measure blood pressure are needed to predict the onset of eclampsia, a condition which causes tens of thousands of annual global deaths. Eclampsia is a dangerous seizure condition which is predicted by preeclampsia, the occurrence of hypertension and protein in the urine in pregnancy. Experts estimate that approximately half of all hypertension in pregnancy is associated with preeclampsia. Devices to measure blood pressure are also necessary in cases of hemorrhage to determine if fluid replacement or transfusion are necessary to save the life of a woman experiencing postpartum hemorrhage.

    Mechanism of Action
    Blood pressure measurement typically involves the occlusion of the brachial artery at approximately the height of the heart using an inflatable cuff. The cuff is slowly deflated, and the device detects the pressure at which blood flow resumes (systolic pressure) and the pressure at which it is fully unencumbered by the cuff (diastolic pressure). In the ausculatory method, the caregiver uses a stethoscope to listen to the Korotkoff sounds as the cuff deflates, noting the pressure at each sound. In the oscillometric method, a pressure transducer in the cuff measures oscillations in the cuff pressure (caused by blood flow) as it deflates. The device then calculates blood pressure and displays it on a digital read out. While these automatic devices do not require the skill and related accuracy challenges of manual devices, some models systematically under report blood pressure.

    Current Use in High-Resource settings
    Several authors have noted the inaccuracy of blood pressure measurement around the world, citing relatively low levels of agreement between sequential observers using manual equipment. Automated, oscillometric equipment is gradually replacing manual equipment, although it must be validated for use with pregnant women and calibrated at regular intervals. There is also movement to phase out mercury sphygmomanometers due to mercury concerns.

    Application in Low-Resource settings
    Manual, ausculatory cuffs are most commonly used in low-resource settings. Given the high level of user error associated with the auscultatory technique, however, the WHO recommends validated, low cost oscillometric blood pressure measurement devices replace older equipment. The WHO further recommends all devices be semi-automatic and solar powered due to concerns over batteries and battery maintenance. These devices are not yet common on the market.

    Related Technologies in Development
    Solar Blood Pressure Monitor (Conway Institute), Solar Blood Pressure Monitor (King's College)

    REPRESENTATIVE DEVICES

    MAKE
    MODEL
    PRICE
    TECH
    STATUS
    NOTES

    Accoson

    Greenlight 300
    $230
    Ausculatory
    Marketed
    Manual, Self-calibrating, Hg-free

    Omron

    M1 Plus
    $70
    Oscillometric
    Marketed
    Semi-automated

    Prestige

    A2-BLK
    $25
    Ausculatory
    Marketed
    Branded Hg device

    Generic

    Kit with steth
    $10
    Ausculatory
    Marketed
    Generic Hg device

    Microlife

    BP 3AS1-2
    $30
    Oscillometric
    Marketed
    Semi-automated

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    TECHNOLOGY CHARACTERISTICS

    OPERATIONAL PARAMETERS

    POTENTIAL OPPORTUNITIES FOR IMPROVEMENT

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Physician, nurse
    Hours
    Minutes

    User error hampers the accuracy of manual devices. Automated devices, validated for use with pregnant patients are promising alternatives, however, ongoing calibration remains a challenge.

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    None for auscultatory devices
    None
    None
    Indoors
    Calibration necessary every 6 months

    Manual devices can be inoperable in noisy environments, furthering the case for validated, automated alternatives. Timely calibration and power requirements can be issues in remote locations. In the absence of affordable solar, mechanical power sources could be considered (e.g., the pressure bulb)

    COST

    Device cost (approximate)
    Cost/course (approximate)
    $15

    WHO recommends that automated devices cost <$25

    OTHER

    Portability
    Regulatory
    Efficacy
    <200g
    Highly dependent on user training

Sources: WHO Technology Summary - GMDN #16173 Blood Pressure Monitor, UMDNS #18325, #18326, #25209 Blood Pressure Monitoring Device. WHO. Blood pressure devices for low resources settings. 2005. Villar et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Intl J of Gynecology and Obstetrics 85 S28-41. Parati G, Ochan Kilma M, Faini A, et al. Field testing results for a new blood pressure measuring device satisfying WHO criteria for use in low resource settings. European Meeting on Hypertension 2009; June 12-16, 2009; Milan, Duley, L. The Global Impact of Preeclampsia and Eclampsia. 2009. Semin Perinatl . 33:130-137.